Comparative Study of the Safety and Efficacy of Clarithromycin Extended-Release Tablets Versus Amoxicillin-Clavulanate for the Treatment of Acute Bacterial Sinusitis

• Status: Completed
• Trial end date: 1969-12-31

Summary

To compare the safety/tolerability and efficacy of a 14-day course of clarithromycin extended-release tablets (2 x 500 mg QD) with that of a 14-day course of amoxicillin-clavulanate tablets (875/125 mg BID) for the treatment of ambulatory subjects with Acute Bacterial Sinusitis (ABS).

• Phase: Phase 3

Details

• Lead Sponsor: Abbott
• Treatments: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Clarithromycin; Clavulanic Acid; Clavulanic Acids